Evidence map›Paper›PMID 26943943›Full record

ArticlePharmaceutical research2016

Visualization and Quantification of Nasal and Olfactory Deposition in a Sectional Adult Nasal Airway Cast.

Jinxiang Xi, Jiayao Eddie Yuan, Yu Zhang, Dannielle Nevorski, Zhaoxuan Wang, Yue Zhou

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 89 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Nose-to-brain drug delivery: from bench to bedside.Translational neurodegeneration · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Computational,Biomedicines · 2023
    Review
  16. Article
  17. Article
  18. Spatial analysis of transnasal olfactory cleft access: a computed tomography study.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jinxiang XiSchool of Engineering and Technology, Central Michigan University, 1200 South Franklin Street, Mount Pleasant, MI, 48858, USA. xi.jinxiang@cmich.edu.
Jiayao Eddie YuanDepartment of Mechanical Engineering, Columbia University, New York, New York, USA.
Yu ZhangSchool of Engineering and Technology, Central Michigan University, 1200 South Franklin Street, Mount Pleasant, MI, 48858, USA.
Dannielle NevorskiSchool of Engineering and Technology, Central Michigan University, 1200 South Franklin Street, Mount Pleasant, MI, 48858, USA.
Zhaoxuan WangSchool of Engineering and Technology, Central Michigan University, 1200 South Franklin Street, Mount Pleasant, MI, 48858, USA.
Yue ZhouAerosol and Respiratory Dosimetry Program, Lovelace Respiratory Research Institute, Albuquerque, New York, USA.
Central Michigan University · USColumbia University · USLovelace Respiratory Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare drug deposition in the nose and olfactory region with different nasal devices and administration techniques. A Sar-Gel based colorimetry method will be developed to quantify local deposition rates.

methodsA sectional nasal airway cast was developed based on an MRI-based nasal airway model to visualize deposition patterns and measure regional dosages. Four nasal spray pumps and four nebulizers were tested with both standard and point-release administration techniques. Delivered dosages were measured using a high-precision scale. The colorimetry correlation for deposited mass was developed via image processing in Matlab and its performance was evaluated through comparison to experimental measurements.

resultsResults show that the majority of nasal spray droplets deposited in the anterior nose while only a small fraction (less than 4.6%) reached the olfactory region. For all nebulizers considered, more droplets went beyond the nasal valve, leading to distinct deposition patterns as a function of both the nebulizer type (droplet size and initial speed) and inhalation flow rate. With the point-release administration, up to 9.0% (±1.9%) of administered drugs were delivered to the olfactory region and 15.7 (±2.4%) to the upper nose using Pari Sinus.

conclusionsStandard nasal devices are inadequate to deliver clinically significant olfactory dosages without excess drug losses in other nasal epitheliums. The Sar-Gel based colorimetry method appears to provide a simple and practical approach to visualize and quantify regional deposition.

Indexed as

Models, AnatomicNebulizers and VaporizersAdministration, InhalationAdultAerosolsAnti-Inflammatory AgentsColorimetryEquipment DesignHumansMagnetic Resonance ImagingMaleNasal MucosaNoseOlfactory BulbTime FactorsAerosolsAnti-Inflammatory Agentscolorimetryintranasal deliverynose-to-brain deliveryolfactorypoint-release

Identifiers

PMID26943943
OpenAlexW2289520509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.